9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
30 hedge funds and large institutions have $4.07M invested in 9 Meters Biopharma in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 14 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
21% less funds holding
Funds holding: 38 → 30 (-8)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
44% less capital invested
Capital invested by funds: $7.23M → $4.07M (-$3.17M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$182K |
| 3 |
Millennium Management
New York
|
+$143K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$135K |
| 5 |
VF
Virtu Financial
New York
|
+$94.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.29M |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$828K |
| 3 |
State Street
Boston,
Massachusetts
|
-$493K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$106K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$90.9K |
NMTR Hedge Fund Activity: Q2 2019 in Review
30 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q2 2019, worth a combined $4.07M — down 44% from $7.23M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NMTR and 8 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 9 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $2M. The largest seller was BlackRock, cutting an estimated $1.29M.
- 30 institutional investors held 9 Meters Biopharma (NMTR) as of Q2 2019, down from 38 in Q1 2019.
- Funds reported $4.07M of 9 Meters Biopharma stock for Q2 2019, down 44% quarter-over-quarter.
- 8 funds opened new 9 Meters Biopharma positions in Q2 2019 and 14 closed out, a net change of -6 holders.
- The largest 9 Meters Biopharma buyer in Q2 2019 was Sabby Management, an estimated $2M added.
- The largest 9 Meters Biopharma seller in Q2 2019 was BlackRock, an estimated $1.29M sold.
Based on aggregated 13F filings for Q2 2019.